Organogenesis Holdings (ORGO) Non-Current Debt (2017 - 2024)

Organogenesis Holdings' Non-Current Debt history runs 8 years deep, the most recent figure standing at $56.2 million for Q3 2024.

• On a quarterly basis, Non-Current Debt fell 9.6% year-over-year to $56.2 million in Q3 2024; TTM through Sep 2024 was $56.2 million, a 9.6% decrease from a year earlier, with the FY2023 full-year figure at $60.7 million, down 8.28% from the prior year.
• Non-Current Debt slipped to $56.2 million in Q3 2024 per ORGO's latest filing, from $57.7 million in the prior quarter.
• Across five years, Non-Current Debt topped out at $74.5 million in Q3 2021 and bottomed at $10.0 million in Q1 2020.
• The 5-year median for Non-Current Debt is $62.1 million (2023), against an average of $57.2 million.
• Across the five-year window, Non-Current Debt sank 75.0% in 2020 and surged 328.76% in 2021, its largest moves.
• Year by year, Non-Current Debt stood at $43.0 million in 2020, then surged by 64.41% to $70.8 million in 2021, then fell by 6.41% to $66.2 million in 2022, then dropped by 8.28% to $60.7 million in 2023, then dropped by 7.56% to $56.2 million in 2024.
• Per Business Quant, the three latest ORGO Non-Current Debt figures stand at $56.2 million (Q3 2024), $57.7 million (Q2 2024), and $59.4 million (Q1 2024).